3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Enrolling by invitation
1
Sponsor Class
INDUSTRY
2
Study Type
Interventional
29
Observational
2
Sponsor
Cancer Type
Breast
98
Thoracic
11
Gynecologic
10
Genitourinary
9
Gastrointestinal
8
Head & Neck
5
Dermatologic
5
Other solid neoplasm
2
Plasma cell
1
Other hematologic neoplasm
1
Other
1
CNS
1
Conditions
Mesothelioma
44
Mesothelioma, Malignant
42
Retinoblastoma
35
Solid Tumor
27
Lung Neoplasms
16
Hematopoietic and Lymphatic System Neoplasm
16
Pancreatic Neoplasms
13
Carcinoma, Non-Small-Cell Lung
13
Unspecified Adult Solid Tumor, Protocol Specific
12
Solid Tumors
11
Solid Tumor, Adult
10
Ovarian Neoplasms
10
Neoplasms
10
Sarcoma
9
Melanoma
9
Carcinoma, Renal Cell
9
Thymus Neoplasms
8
Stomach Neoplasms
8
Esophageal Neoplasms
8
Breast Neoplasms
8
Small Cell Lung Carcinoma
7
Colonic Neoplasms
7
Urinary Bladder Neoplasms
6
Prostatic Neoplasms
6
Colorectal Neoplasms
6
Uterine Cervical Neoplasms
5
Thymoma
5
Neoplasms, Unknown Primary
5
Kidney Neoplasms
5
Cholangiocarcinoma
5
Interventions
Blood Component Removal
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Observational
×
Triple Negative Breast Neoplasms
×
Other solid neoplasm
×
Clear all
NCT04981119
2026-06-02
BASECAMP-1
A2 Biotherapeutics Inc.
Recruiting
200 enrolled
NCT06885424
2026-05-20
DESCENT-1
A2 Biotherapeutics Inc.
Enrolling by invitation
400 enrolled